Board of Directors

Slay Sarcoma Research Initiative was incorporated December 31st, 2015 and became a non-profit 501(c)3 approved organization on June 6th, 2016.  

The sole mission of the SSRI Inc. is to find a cure for leiomyosarcoma.  This will be accomplished by promoting awareness, fund-raising for scientific grant award distribution, and donations to organizations and individuals to this end.

JoAnn B. Trainer, Pharm D
Chief Executive Officer
Scientific Advisor
Conflict of Interest Officer

Andrea Kealy, MEd
President
Technological Advisor

Sarah Trainer
Treasurer